EMA Authorised: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) — Cordex Biologics International Limited

View source ↗

Summary

EMA has authorised Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded; dorocubicel) for hematologic neoplasms and hematopoietic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Hematopoietic Stem Cell Transplantation

Drugs mentioned

• Zemcelpro

Snippet

Status: Authorised. Therapeutic area: Hematologic Neoplasms;Hematopoietic Stem Cell Transplantation. MAH: Cordex Biologics International Limited. Decision date: 08/07/2026. Conditional approval. Orphan medicine